NMRA — Neumora Therapeutics News Story

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

All News

Neumora Therapeutics scraps depression drug after two late-stage trial failures

Neumora Therapeutics

15/06/2026 13:04

Neumora Therapeutics scraps depression drug after two late-stage trial failuresJune 15 (Reuters) - Neumora Therapeutics NMRA.O said on Monday it would stop developing its depression drug after two late-stage trials failed to meet their main goals.








 (Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi Majumdar)
 ((Kamal.Choudhury@thomsonreuters.com;))

NMRA — Neumora Therapeutics News Story

Neumora Therapeutics scraps depression drug after two late-stage trial failures

Recent news on Neumora Therapeutics

Neumora Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Brief: Neumora Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update

Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview

Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview

U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex